ERCC4 and lung carcinoma: MMC treatment not only cross-links DNA but also inhibits expression of SPTAN1 through miR-128-3p to disrupt recruitment of DNA repair-associated proteins (FANCA and XPF), with dual destructive effects in lung cancer cells.